Showing results (411-420 of 1,369) with videos related to
Sort By:
Pageof 137
Trends in Immunology|August 20, 2013
A balance of interleukin-12 and -23 in cancerShin Foong Ngiow, Michele W L Teng, Mark J SmythClinical Ophthalmology (Auckland, N.Z.)|June 1, 2018
An ex vivo human aqueous humor-concentration comparison of two commercial bromfenac formulationsThomas R Walters, Robert J Smyth-Medina, Paul C CockrumImmunological Reviews|November 18, 2004
Cytokines in cancer immunity and immunotherapyMark J Smyth, Erika Cretney, Michael H Kershaw, et al.The Journal of Experimental Medicine|November 2, 1999
Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancersJ Zhang, I Scordi, M J Smyth, et al.Nature Reviews. Clinical Oncology|December 8, 2018
Cancer immunoediting and resistance to T cell-based immunotherapyJake S O'Donnell, Michele W L Teng, Mark J SmythTrends in Biotechnology|June 19, 2016
EU Failing FAO Challenge to Improve Global Food SecurityStuart J Smyth, Peter W B Phillips, William A KerrBreast Cancer Research and Treatment|November 1, 2002
Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycleNamita Kundu, Miriam J Smyth, Leigh Samsel, et al.Journal of Virology|April 29, 1998
Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolateR J Smyth, Y Yi, A Singh, et al.Molecular Microbiology|September 25, 2004
Dimerization properties of TraM, the antiactivator that modulates TraR-mediated quorum-dependent expression of the Ti plasmid tra genesYinping Qin, Audra J Smyth, Shengchang Su, et al.Cancer Research|October 20, 2011
Prospects for TIM3-Targeted Antitumor ImmunotherapyShin Foong Ngiow, Michele W L Teng, Mark J SmythPageof 137